Share on StockTwits

ICU Medical, (NASDAQ:ICUI) Director George A. Lopez sold 23,000 shares of ICU Medical, stock on the open market in a transaction dated Monday, May 12th. The shares were sold at an average price of $60.42, for a total transaction of $1,389,660.00. Following the completion of the transaction, the director now directly owns 450,235 shares of the company’s stock, valued at approximately $27,203,199. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

ICU Medical, (NASDAQ:ICUI) traded up 0.97% on Monday, hitting $60.12. The stock had a trading volume of 160,250 shares. ICU Medical, has a one year low of $54.00 and a one year high of $85.00. The stock’s 50-day moving average is $57.77 and its 200-day moving average is $61.53. The company has a market cap of $914.4 million and a price-to-earnings ratio of 23.84.

ICU Medical, (NASDAQ:ICUI) last posted its quarterly earnings results on Tuesday, May 6th. The company reported $0.43 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.32 by $0.11. The company had revenue of $73.20 million for the quarter, compared to the consensus estimate of $70.79 million. During the same quarter in the prior year, the company posted $0.58 earnings per share. The company’s quarterly revenue was down 1.5% on a year-over-year basis. Analysts expect that ICU Medical, will post $1.38 EPS for the current fiscal year.

A number of research firms have recently commented on ICUI. Analysts at TheStreet downgraded shares of ICU Medical, from a “buy” rating to a “hold” rating in a research note on Thursday. Separately, analysts at Zacks upgraded shares of ICU Medical, from an “underperform” rating to a “neutral” rating in a research note on Wednesday, April 23rd. They now have a $58.50 price target on the stock. Finally, analysts at Zacks downgraded shares of ICU Medical, from a “neutral” rating to an “underperform” rating in a research note on Tuesday, February 25th. They now have a $56.80 price target on the stock. Five equities research analysts have rated the stock with a hold rating, The stock presently has a consensus rating of “Hold” and a consensus target price of $63.88.

ICU Medical, Inc is engaged in the development, manufacture and sale of medical devices used in infusion therapy, oncology and critical care applications.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.